A consultant accused of fiddling a potentially lucrative drug trial did not tell his boss he had a financial interest in the results, a hearing was told today (TUES).
Dr Goran Jamal, 49, had been
This content is for members with full access only.
Please upgrade your membership on your account page to access it.
Upgrade your account